The effect of primary and secondary cardiovascular prevention on different biomarkers and body composition, a single-centre study from Hungary

4 April 2025 (09:00 - 18:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Fanni Molnar

University of Pecs, Pecs (Hungary)

87 More presentations in this session

Presentation thumbnail

Comparative efficacy and safety of antithrombotic regimens following left atrial appendage occlusion therapy in atrial fibrillation patients: a comprehensive Bayesian network meta-analysis

Doctor V. Lanari (Milan, IT)

Abstract Slides

Presentation thumbnail

Paroxysmal atrial fibrillation prediction score based on 24-hours electrocardiogram-monitoring data

Doctor G. Galati (Milan, IT)

Abstract Slides

Presentation thumbnail

Is excessive epicardial fat volume in asymptomatic young adult subjects with normal calcium score the trigger for abnormal ECGs and arrhythmia?

Doctor A. Sabatini (Florence, IT)

Abstract Slides

Presentation thumbnail

Prevention of readmission in the acute setting for heart failure patients: an adapted protocol of levosimendan infusion in inpatient high-intensity cardiac rehabilitation

Doctor I. Cusmano (Milan, IT)

Abstract Slides

Presentation thumbnail

Enhanced external counterpulsation (EECP) as a strategy for left ventricular and microcirculatory improvement: independent of cardiac intervention

Doctor O. Handayani (Jakarta, ID)

Abstract Slides

Access the full session

Session thumbnail

Poster session (2)

The Event

Event poster

ESC Preventive Cardiology 2025

4 April 2025 09:00 CET

You may be interested in

Webinar

Personalised secondary prevention post-ACS: the role of biomarkers

Webinar

Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum

Congress Presentation

Optimal medical therapy for primary prevention

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources